What you Need and When – The Key Documents in the Drug Lifecycle - Trilogy Writing & Consulting GmbH
Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization | NEJM
![PDF] Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3373dba5e016c74950f7ca66bc88adc348737a4a/7-Table3-1.png "PDF] Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial. | Semantic Scholar")
PDF] Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial. | Semantic Scholar
Summary of results of published clinical trials assessing... | Download Table
MeMed Completes Trilogy of Clinical Studies with More Than 2,000 Patients Validating First Ever Blood Test to Accurately Distinguish Between Bacterial and Viral Infections
Clinical Cardiology: Vol 39, No 9
Philips Introduces Trilogy Evo Ventilator | RT
On behalf of the TRILOGY ACS Investigators Prasugrel versus clopidogrel for patients with UA/NSTEMI medically managed after angiographic triage — Results. - ppt download
MeMed Completes Trilogy of Clinical Studies with More Than 2,000 Patients Validating First Ever Blood Test to Accurately Distinguish Between Bacterial and Viral Infections
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS. - ppt video online download
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol - Respiratory
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS. - ppt video online download
JenaValve on Twitter: "JenaValve has successfully treated our 100th patient with Aortic Regurgitation using the Trilogy Heart Valve System. A special thank you to all of our ALIGN-AR Clinical Trial Sites for
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD | NEJM
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease ( TRILOGY): a double-blind, parallel group, randomised controlled trial - The Lancet
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation | European Respiratory Society
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease ( TRILOGY): a double-blind, parallel group, randomised controlled trial - The Lancet
Solution Circle: Writing for Patients and the Summary of Clinical Trial Results
The Lancet on Twitter: "Single inhaler triple therapy for COPD - findings from the TRILOGY trial #ERSLDN2016 https://t.co/owtm3JsdkM https://t.co/TuqctwP3VC" / Twitter
Noninvasive Ventilation via Philips Respironics Trilogy 100 Reduces COPD Readmission Rates, Royal Philips Study Shows
TRILOGY Phase 3 - DELETE? :: Acasti Pharma Inc. (ACST)
Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD | COPD
Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements | Scientific Reports
Trilogy - Solutions/Service Company
